CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-kappaB
1Department of Molecular Biology, Cancer Research Institute, Sapporo Medical University, Hokkaido, Sapporo, Japan.
Abstract:
The mitotic checkpoint gene CHFR (checkpoint with forkhead and ring finger domains) is silenced in various human cancers by promoter hypermethylation, suggesting that CHFR is a tumor suppressor. Here, we show that CHFR functions as a negative regulator of the nuclear factor-kappaB (NF-kappaB) pathway. Expression of CHFR inhibited NF-kappaB reporter activity, whereas knockdown of CHFR activated reporter activity. These activities are independent of its RING finger domain. Furthermore, we found that CHFR physically interacts with p65 in cells. Electrophoretic mobility shift assays (EMSAs) and ELISA-based NF-kappaB-binding assays showed that CHFR negatively regulated transcriptional activity of p65. In addition, our data show that interleukin (IL)-8 is significantly downregulated by CHFR, and that the migration of human endothelial cells is suppressed in culture medium conditioned from CHFR-expressing cancer cells. Using a xenograft model, we show that neovascularization is suppressed by adenovirus-mediated transfer of CHFR. These results indicate that expression of CHFR markedly reduces the expression of IL-8 through the inhibition of NF-kappaB. As the NF-kappaB signaling pathway plays a critical role in the development and progression of cancer, our findings show the functional relationship between epigenetic alteration and inflammation/angiogenesis in human cancer cells, thereby showing several potential targets for therapeutic intervention.
Insights
The tumor suppressor CHFR (checkpoint with forkhead and ring finger domains) silences the NF-kappaB pathway, reducing IL-8 expression and suppressing cancer cell migration and angiogenesis.
Area of Science:
- Molecular biology
- Cancer research
- Epigenetics
Background:
- The CHFR (checkpoint with forkhead and ring finger domains) gene is silenced in various human cancers via promoter hypermethylation, indicating its role as a tumor suppressor.
- The nuclear factor-kappaB (NF-kappaB) signaling pathway is crucial in cancer development and progression, regulating inflammation and angiogenesis.
Purpose of the Study:
- To elucidate the function of CHFR in regulating the NF-kappaB pathway.
- To investigate the impact of CHFR on downstream targets like IL-8 and cellular processes such as endothelial cell migration and neovascularization.
Main Methods:
- Reporter assays to assess NF-kappaB activity.
- CHFR knockdown and expression studies.
- Co-immunoprecipitation to detect protein interactions.
- Electrophoretic mobility shift assays (EMSAs) and ELISA-based binding assays.
- In vitro endothelial cell migration assays.
- In vivo xenograft models with adenovirus-mediated CHFR transfer.
Main Results:
- CHFR acts as a negative regulator of the NF-kappaB pathway, independent of its RING finger domain.
- CHFR physically interacts with p65 and inhibits its transcriptional activity, leading to downregulation of IL-8.
- CHFR expression suppresses human endothelial cell migration and neovascularization in vivo.
Conclusions:
- CHFR inhibits NF-kappaB signaling, thereby reducing IL-8 expression, inflammation, and angiogenesis.
- These findings reveal a link between epigenetic silencing of CHFR, inflammation, and angiogenesis in cancer.
- CHFR represents a potential therapeutic target for cancer intervention.
More Related Videos
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
